Why do some lung cancer patients have shorter responses to TKIs? – Oncogene Cancer Research

Oncogene Cancer Research shared a post on X:

“Why do some lung cancer patients have shorter responses to TKIs?

CU Anschutz Medical Campus is studying just this and the role of the patients’ own immune systems.

Goal to identify a treatment that could improve the performance of TKIs in those less responsive.”

Additional information.
Source: Oncogene Cancer Research/X